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Objective: We sought to explore the usefulness of the Risk Adjustment in Congen-
ital Heart Surgery method (designated RACHS-1) of adjusting for case-mix differ-
ences when comparing institutional mortality after surgery for congenital heart
disease.
Methods: By using 1996 hospital discharge data from 6 states, centers performing
at least 100 operations for congenital heart disease (patient age 18 years) were
identified. Using the RACHS-1 method, procedures were grouped into 6 risk
categories, and institutions were ranked in order of increasing mortality rate. A
graphic display of ranks by risk category identified patterns of performance. Incor-
porating age, prematurity, and presence of a major noncardiac structural anomaly
into multivariate models allowed computation of an overall risk-adjusted rank for
each institution on the basis of its standardized mortality ratio.
Results: Among 109 centers performing 7177 operations for congenital heart
disease, 22 performed at least 100 cases (72.3% of total operations). Unadjusted
mortality rates ranged from 2.5% to 11.4%. A total of 4318 cases could be placed
into 1 of the 6 risk categories. Few deaths occurred in risk category 1, and few
institutions performed procedures in risk categories 5 and 6, making institutional
comparisons in these categories uninformative. Considering mortality rates in
categories 2 through 4, institutions displayed either relatively consistent ranks, a
threshold increase in mortality as higher-risk procedures were performed, or a
threshold decrease in mortality. Standardized mortality ratios indicated which
institutions performed better or worse than expected on the basis of their case mix.
Conclusions: The RACHS-1 method can be used to judge relative institutional
performance, either by evaluating within-risk-category differences or by compari-
sons of observed and expected mortality rates.
Operations for congenital heart disease carry a significant risk ofdeath for all but the simplest lesions. We and others1-7 havedemonstrated considerable differences in mortality among insti-tutions performing cardiac surgery in children. For individualcenters, quality-improvement efforts can be stimulated by infor-mation about how one center is performing relative to others.
Simple comparisons of overall mortality rates are not useful because of baseline
differences in risk among individuals. Risk adjustment for adult cardiac procedures
is easier than it is for pediatric procedures because there is less variation in the
anatomy and physiology. For pediatric cardiac surgery, case-mix differences be-
tween institutions lie in the marked anatomic variation of the underlying disease and
thus in the nature of the surgical procedure required for correction. Lesion-specific
approaches have limited precision because even common lesions represent only a
small fraction of the annual surgical caseload for a center. Despite its importance,
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Table 1. Individual procedures by risk category
Risk category 1
ASD surgery (including ASD secundum, sinus venosus ASD, patent foramen ovale closure)
Aortopexy
Patent ductus arteriosus surgery 30 d of age
Coarctation repair 30 d of age
Partially anomalous pulmonary venous connection surgery
Risk category 2





Pulmonary outflow tract augmentation
Repair of coronary AV fistula
ASD and VSD repair
ASD primum repair
VSD repair
VSD closure and pulmonary valvotomy or infundibular resection
VSD closure and pulmonary artery band removal
Repair of unspecified septal defect
Total repair of tetralogy of Fallot
Repair of total anomalous pulmonary veins 30 d of age
Glenn shunt
Vascular ring surgery
Repair of AP window
Coarctation repair 30 d of age
Repair of pulmonary artery stenosis
Transection of pulmonary artery
Common atrium closure









Valvectomy of tricuspid valve
Tricuspid valvotomy-valvuloplasty
Tricuspid valve replacement
Tricuspid valve repositioning for Ebstein 30 d of age
Repair of anomalous coronary artery without intrapulmonary tunnel
Repair of anomalous coronary artery with intrapulmonary tunnel (Takeuchi)
Closure of semilunar valve, aortic or pulmonary
Right ventricular to pulmonary artery conduit
Left ventricular to pulmonary artery conduit
Repair of double-outlet right ventricle with or without repair of right ventricular obstruction
Fontan procedure
Repair of transitional or complete atrioventricular canal with or without valve replacement
Pulmonary artery band
Repair of tetralogy of Fallot with pulmonary atresia
Repair of cor triatriatum
Systemic to pulmonary artery shunt
Atrial switch operation
Arterial switch operation
Reimplantation of anomalous pulmonary artery
Annuloplasty
Repair of coarctation and VSD closure
Excision of intracardiac tumor
(Continued on next page)
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estimating overall institutional performance for pediatric
cardiac surgical centers can be challenging.
We have recently developed a consensus-based method
to adjust for case-mix differences when comparing in-hos-
pital mortality for groups of children undergoing surgery for
congenital heart disease.8 Our method can provide reason-
able estimates of overall institutional performance with
fairly modest data requirements. To explore the usefulness
of this new research tool, we analyzed hospital discharge
data from centers with large surgical volumes in 6 states
using the Risk Adjustment in Congenital Heart Surgery
(RACHS-1) method. Our analyses uncovered several dis-
tinct patterns of programmatic outcomes, which should as-
sist in program-specific efforts to reduce mortality.
Methods
Data Sources
We obtained and analyzed 1996 hospital discharge data from 6
states (California, Illinois, Massachusetts, New York, Pennsylva-
nia, and Washington). These data sets contain information for each
hospital discharge occurring within the year in standard formats.
Up to 10 ICD-9-CM9 procedure codes and 25 diagnosis codes
were available within each data set, along with additional patient
and billing information. By using previously described algorithms,
we selected abstracts from children less than 18 years of age with
codes indicating surgical repair of a congenital heart defect.8 Cases
with codes for cardiac transplantation or interventional catheter-
ization procedures were eliminated, as were cases involving new-
borns 30 days of age or younger undergoing ligation of a patent
ductus arteriosus only. The total annual case volume for cardiac
surgical cases meeting the above criteria was then computed for
each center, and the 22 institutions with codes indicating cardiac
surgery in at least 100 discharges per year were analyzed further.
Analysis of Unadjusted Mortality Rates
For each institution performing at least 100 cardiac surgical cases
per year, an overall mortality rate was calculated for the entire
caseload. Institutions were ranked in order of increasing mortality
from 1 (lowest mortality) to 22 (highest mortality).
Application of the RACHS-1 Method
The RACHS-1 method can be applied in 2 ways. The simpler
approach groups procedures with similar expected short-term mor-
tality rates into 6 predefined risk categories, in which category 1
has the lowest risk for death and category 6 the highest (Table 1),
and examines mortality separately within each category. The more
complex multivariate method incorporates 4 additional clinical
factors: age stratified as 30 days or less, 31 days to 1 year, and 1
year or older; prematurity identified by the presence of appropriate
ICD-9-CM diagnosis codes; presence of a major noncardiac struc-
tural anomaly in addition to the cardiac defect (eg, tracheoesoph-
ageal fistula, cleft lip, or palate); and presence of combinations of
cardiac surgical procedures.
Using computer algorithms, we assigned cases to 1 of the 6 risk
categories. Unassigned cases, typically those having codes with
vague descriptions, such as “revision of procedure,” were ex-
cluded. Surgical cases with combinations of cardiac procedures
performed simultaneously (eg, coarctation of the aorta and ven-
tricular septal defect closure) were placed in the category corre-
Table 1—Continued
Risk category 4
Aortic valvotomy-valvuloplasty 30 d of age
Konno procedure
Repair of complex anomaly (single ventricle) by VSD enlargement
Repair of total anomalous pulmonary veins 30 d of age
Atrial septectomy
Repair of transposition-VSD-sub PS (Rastelli)
Atrial switch operation with VSD closure
Atrial switch operation with repair of sub PS
Arterial switch operation with pulmonary artery band removal
Arterial switch operation with VSD closure
Arterial switch operation with repair of sub PS
Repair of truncus arteriosus
Repair of hypoplastic or interrupted arch without VSD closure
Repair of hypoplastic or interrupted aortic arch with VSD closure
Transverse arch graft
Unifocalization for tetralogy of Fallot-pulmonary atresia
Double switch
Risk category 5
Tricuspid valve repositioning for neonatal Ebstein 30 d of age
Repair of truncus arteriosus and interrupted arch
Risk category 6
Stage 1 repair of hypoplastic left heart syndrome (Norwood operation)
Stage 1 repair of nonhypoplastic left heart syndrome conditions
Damus-Kaye-Stansel procedure
ASD, Atrial septal defect; AV, atrioventricular; VSD, ventricular septal defect; AP, aortopulmonary; sub PS, subpulmonic stenosis.
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sponding to the single highest-risk procedure. A category-specific
mortality rate was calculated for each institution with at least 10
cases in that category to apply the simpler method of adjustment;
centers were then ranked in order of increasing mortality. A
graphic display of ranks by risk category was constructed for each
institution, and graphs were inspected to identify overall patterns.
Application of the more complex method allows computation
of an overall risk-adjusted rank for each institution, incorporating
nearly the entire institutional caseload into a single measure of
performance. To begin, expected mortality rates, adjusting for case
mix, were calculated for each center. Risk categories 2, 3, 4, and
6 (no cases were placed in risk category 5, which contains very few
procedures) were used as binary covariates in a logistic regression
model predicting mortality, with category 1 as the reference group.
The resulting model was then used to calculate the predicted
probability of death for each individual case in the data set. The
average predicted probability of death for all cases within a par-
ticular institution, which was calculated by summing the predicted
probabilities for each case and dividing by the total number of
cases, represents the expected mortality rate for that center, ad-
justing for case mix. The observed and expected mortality rates
were compared by calculating the standardized mortality ratio
(SMR) for each center, which was defined as the observed mor-
tality rate divided by the expected mortality rate. If the observed
mortality rate for an institution is higher than expected, meaning
that the center performs worse than would be expected given its
case mix, the SMR is greater than 1. If the institution’s observed
mortality rate is lower than expected, indicating better perform-
ance than would be anticipated, the SMR is less than 1. Institutions
can then be ranked from lowest to highest on the basis of their
individual SMR values, providing an assessment of relative per-
formance for the overall caseload.
Similar methodology can be applied for the 4 additional clinical
factors to improve the case-mix adjustment further. Binary covari-
ates representing age 30 days or less, age 31 days to 1 year,
prematurity, presence of a major noncardiac structural anomaly,
and presence of combinations of cardiac surgical procedures were
included in the logistic regression model already containing risk
category. The resulting model was used to calculate the predicted
probability of death for each patient in the data set; the average
predicted probability of death for all patients within a particular
institution is the expected mortality rate for that center, adjusting
for risk category and the other clinical factors. Once again, ob-
served and expected mortality rates for each institution were
compared using SMR values, and institutions were ranked accord-
ing to increasing SMR.
A 95% confidence interval was calculated for each SMR.10 If
the confidence interval contains the value 1, the difference in
observed versus expected rates is not considered to be statistically
significant.
Results
In 6 states 7177 cases of surgery for congenital heart disease
were identified in children less than 18 years of age. These
cases were performed at 109 institutions, with a median
annual case volume of 11 (range, 1-587 cases). Of these
centers, 22 performed at least 100 cases, accounting for
72.3% of the total surgical procedures performed. The mor-
tality rate for the entire data set was 5.6%. The 22 large
institutions had an overall mortality rate of 4.0%, whereas
the 87 smaller institutions had a mortality rate of 9.8%. The
range in unadjusted mortality rates for the 22 large centers
was 2.5% to 11.4%, with a median of 5.6%. Using blinded
alphabet codes, the ranked mortality rates for each institu-
tion are shown in Table 2.
A total of 4318 (83.2%) cases could be placed into 1 of
the 6 risk categories; the remaining cases were uncategoriz-
able and are not included in further analyses. Institution-
specific mortality rates for only those cases assigned to a
risk category are shown in Table 2; for these cases, the
range in unadjusted mortality rates was 1.7% to 11.0%, with
a median of 4.5%.
The caseload for each institution was then stratified by
risk category. No cases were identified in category 5; this
category was therefore excluded from further analyses.
Within each of the remaining risk categories, mortality rates
were computed for institutions performing 10 or more cases
within that category. All 22 institutions performed at least
10 cases in risk categories 1, 2, and 3; 10 institutions
performed 10 or more cases in category 4; and only 3
institutions performed 10 or more cases in category 6.
Institutional mortality rates for each risk category are shown
in Figure 1.
Within each risk category, institutions were ranked in
order of increasing mortality rate. Very few deaths occurred
in risk category 1, and thus relative institutional perform-
ance in this category was not meaningful. Similarly, too few
institutions performed procedures in risk category 6 to make
informative comparisons. Considerable variation in mortal-
ity was observed in categories 2, 3, and 4. In category 2
mortality rates ranged from 0% to 8.8% (median, 2.5%),
whereas rates ranged from 0% to 20.8% (median, 4.6%) in
category 3 and from 5.3% to 40% (median, 10.4%) in
category 4. Graphs of the mortality rate rankings within
these 3 risk categories for each institution are shown in
Figure 2. Because all 22 institutions are ranked in categories
2 and 3 but only 10 are ranked in category 4, the graph
displays the relative ranking for each center, defined as the
absolute rank divided by the total number of institutions
ranked in that risk category. Thus, for example, the institu-
tion receiving rank 11 in risk category 2 would be assigned
a relative rank of 11/22  0.5; similarly, the institution
receiving rank 5 in risk category 4 would be assigned a
relative rank of 5/10  0.5.
Inspection of the 22 sets of rankings revealed overall
patterns of some interest for each institution (Figure 3).
Twelve institutions have consistent relative rankings for
each of the 2 or 3 risk categories in which they are ranked
(Figure 3, A). For these institutions, relative performance
can be classified as being consistently good, average, or
poor. Five institutions seem to have a threshold increase in
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mortality: as higher-risk procedures are performed, relative
rankings increase (Figure 3, B). In all instances worse
performance occurs between categories 2 and 3. The 5
remaining institutions seem to have a threshold decrease in
mortality: as higher-risk procedures are performed, relative
rankings improve (Figure 3, C). Four centers show worse
ranks for category 2 than for categories 3 and 4, and one has
poorer ranks in categories 2 and 3 relative to category 4.
Expected mortality rates and SMRs for each institution
are shown in Table 2 to assess overall institutional perform-
ance adjusted for risk category. Ranks are assigned accord-
ing to increasing SMR.
Expected mortality rates and SMRs adjusting for age,
prematurity, presence of a major noncardiac structural
anomaly, and combinations of cardiac procedures in addi-
tion to risk category are also shown in Table 2 to refine the
Table 2. Observed and expected mortality rates by institution
Center
All cases




Adjusted for risk category and additional clinical
factors




MR SMR 95% CI Rank
C 2.5% 1 1.9% 2 4.5% 2 4.5% 0.43 (0.09-1.25) 1
D 3.6% 7 2.2% 4 4.8% 3 4.7% 0.48 (0.15-1.11) 2
H 2.7% 3 1.7% 1 4.1% 1 3.3% 0.51 (0.10-1.48) 3
E 2.9% 4 2.4% 5 5.0% 4 4.6% 0.53 (0.27-0.92) 4
M 3.7% 8 3.4% 7 5.1% 6 5.3% 0.64 (0.32-1.15) 5
F 2.5% 2 3.0% 6 4.7% 5 4.5% 0.67 (0.13-1.96) 6
G 5.5% 11 5.6% 17 6.6% 9 7.0% 0.80 (0.50-1.23) 7
S 3.1% 5 2.0% 3 2.7% 7 2.4% 0.83 (0.09-3.00) 8
U 6.3% 15 4.2% 9 5.2% 8 4.7% 0.89 (0.44-1.60) 9
I 5.6% 12 4.2% 9 4.4% 10 4.5% 0.92 (0.49-1.58) 10
T 4.8% 9 4.5% 11 4.1% 11 4.2% 1.06 (0.34-2.49) 11
V 3.4% 6 3.9% 8 3.5% 12 3.4% 1.12 (0.30-2.86) 12
R 6.1% 14 5.1% 13 4.5% 14 4.3% 1.20 (0.44-2.60) 13
K 6.4% 16 5.2% 14 4.5% 13 4.3% 1.21 (0.60-2.16) 14
J 6.5% 17 6.2% 18 4.9% 16 4.9% 1.25 (0.67-2.14) 15
Q 6.7% 18 5.5% 16 4.3% 17 4.4% 1.26 (0.70-2.07) 16
L 8.8% 19 7.8% 19 4.3% 19 5.3% 1.47 (0.63-2.89) 17
A 5.0% 10 4.6% 12 3.7% 15 3.1% 1.50 (0.40-3.85) 18
O 6.0% 13 5.4% 15 3.6% 18 3.6% 1.51 (0.55-3.28) 19
N 11.4% 22 10.1% 21 5.1% 20 6.5% 1.56 (0.80-2.72) 20
P 10.0% 20 9.8% 20 3.9% 22 4.8% 2.02 (0.92-3.84) 21
B 10.7% 21 11.0% 22 5.2% 21 5.2% 2.11 (1.40-3.05) 22
MR, Mortality rate; SMR, standardized mortality ratio (ie, observed MR/expected MR); CI, confidence interval.
Figure 1. Institution-specific mortality rates for cases in risk categories 1, 2, 3, 4, and 6.
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case-mix adjustment further. The rankings displayed only
minor changes.
The additional information provided by the more com-
plex multivariate risk-adjustment method can be inferred
from inspection of the expected institutional mortality rates
in Table 2. Although the mortality rate for the group as a
whole is 4.0%, the expected mortality rates at each institu-
tion vary nearly 3-fold, from 2.4% to 7.0%.
Discussion
Quality-improvement efforts can be enhanced and stimu-
lated by a clear understanding of how an institution is
performing in comparison with other institutions, as well as
how its performance is changing over time. In this report we
used the newly developed RACHS-1 method to try to un-
derstand differences in short-term mortality for congenital
heart procedures. We analyzed 1996 hospital discharge data
from 22 institutions in 6 states, each performing at least 100
operations for congenital heart disease in children. By lim-
iting the study to centers with larger case volumes, we
hoped to reduce volume-dependent effects; volume has
been shown to be a determinant of center-specific differ-
ences in mortality.1-7
Despite the broad diversity of procedures performed at
each of the centers, we were able to create risk-adjusted
measures and rankings of overall performance for each
institution. We applied the RACHS-1 methodology to ex-
amine risk category–specific mortality rates and to calculate
SMRs, adjusting for risk category and other clinical factors.
Although most of the descriptive information could be
derived from the simpler method, which adjusted for risk
category only, the incorporation of additional clinical fac-
tors also explained some of the differences in observed
mortality, as evidenced by the changes in expected mortal-
ity rates when these additional variables were incorporated
into the model.
In addition to the institutional performance rankings
listed in Table 2, important insights about mortality differ-
ences have come from analysis of the information within
each risk category. All of the institutions in our analysis
were able to perform procedures in risk category 1 with
little, if any, mortality. For higher-risk procedures, several
distinct patterns emerged. Some institutions displayed a
consistent relative performance across risk categories. For
institutions performing at better than average levels, focus
should be placed on improving outcomes for higher-risk
procedures, especially those in categories 4 and 6, in which
overall mortality rates remain high. Institutions performing
considerably worse than average for all risk categories may
need to consider global, rather than incremental, program-
matic changes. Several institutions showed worsening per-
formance for higher-risk procedures. These patterns may
suggest that institutions should consider targeted referral to
centers with better performance or other measures to im-
prove performance for higher-risk procedures. Some insti-
tutions displayed an interesting pattern of poorer perform-
ance for lower-risk than for higher-risk procedures. For
programs with this pattern, careful intrainstitutional assess-
ment should be made of possible systematic differences (eg,
assignment of certain types of cases to specific surgeons and
location of postoperative care) in the way that simpler cases
are handled in comparison with more complex ones. In any
case the finding of increasing or decreasing risk-adjusted
performance as complexity increases should prompt fo-
cused inquiries within institutions about potential explana-
tory factors.
Although analyses such as these should prompt inquiry,
definitive conclusions about quality of care at individual
Figure 2. Relative ranks for institution-specific mortality rates in risk categories 2, 3, and 4. Relative ranks are
defined as the absolute rank divided by the total number of institutions ranked in that risk category.
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centers should not be made from this type of investigation.
Data analyses should be considered exploratory, given the
many possible competing explanations for higher-than-ex-
pected death rates at some institutions, including data-cod-
ing errors, case-mix differences insufficiently accounted for
with the RACHS-1 method, and chance variability, espe-
cially for the analysis of a single time period. Nearly all of
the differences demonstrated did not reach statistical signif-
icance in this single calendar year. Furthermore, inaccura-
cies in the data may be present because hospital discharge
data are collected primarily to support billing and are ver-
ified by various statewide agencies charged with this pur-
Figure 3. Relative ranks for institution-specific mortality rates in risk categories 2, 3, and 4 separated into
institutions with nearly equivalent rankings in all risk categories (A), institutions with a threshold increase in
mortality as higher-risk procedures are performed (B), and institutions with a threshold decrease in mortality as
higher-risk procedures are performed (C).
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pose and not by investigators. We suspect that procedures
might be more accurately coded than diagnoses as a part of
the billing process, but this has not been tested. Similarly,
despite its importance, in-hospital mortality is only one of
the clinically important end points that should be of interest
to program directors. Relative performance with respect to
late mortality and functional and neurologic outcomes, as
examples, would also be of obvious interest for efforts at
quality improvement. Such analyses would require specific
data collection and the development of risk-adjustment tools
beyond RACHS-1. Better data sets would clearly improve
the accuracy of overall assessments in general.
Summary
The primary purpose of this study was to test whether the
newly created RACHS-1 method could improve under-
standing of institution-specific mortality for congenital heart
surgery. As a first step, use of the method seemed success-
ful: the variation in both unadjusted (2.5%-11.4%) and
expected (2.4%-7.0%) mortality rates at the 22 institutions
reconfirms the importance of risk-adjustment techniques in
assessing institutional performance. In addition, despite lim-
iting analyses to institutions performing larger caseloads
and using risk adjustment, some institutions performed sub-
stantially better or worse than expected. Although most
differences were not statistically significant in this single
calendar year, interesting possibilities for targeted improve-
ments may come from a center-by-center analysis of per-
formance in different risk categories. In combination, these
observations would seem to confirm the need for risk ad-
justment when comparing short-term mortality after surgery
for congenital heart disease, as well as supporting the po-
tential utility of the RACHS-1 method.
We thank Ms Deborah Quigley and Mr Gary Piercey for their
programming and administrative assistance with this project.
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